106 related articles for article (PubMed ID: 17172987)
1. Glycogen synthase kinase 3beta inhibition reduces the development of nonseptic shock induced by zymosan in mice.
Cuzzocrea S; Di Paola R; Mazzon E; Crisafulli C; Genovese T; Muià C; Abdelrahman M; Esposito E; Thiemermann C
Shock; 2007 Jan; 27(1):97-107. PubMed ID: 17172987
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Fulia F; Cuzzocrea E; Di Rosa M; Caputi AP; Thiemermann C
Crit Care Med; 2004 Feb; 32(2):457-66. PubMed ID: 14758164
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse.
Cuzzocrea S; Mazzon E; Di Paola R; Muià C; Crisafulli C; Dugo L; Collin M; Britti D; Caputi AP; Thiemermann C
Clin Immunol; 2006 Jul; 120(1):57-67. PubMed ID: 16631408
[TBL] [Abstract][Full Text] [Related]
4. Green tea polyphenol extract attenuates zymosan-induced non-septic shock in mice.
Di Paola R; Mazzon E; Muià C; Crisafulli C; Genovese T; Di Bella P; Esposito E; Menegazzi M; Meli R; Suzuki H; Cuzzocrea S
Shock; 2006 Oct; 26(4):402-9. PubMed ID: 16980889
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice.
Cuzzocrea S; Di Paola R; Mazzon E; Patel NS; Genovese T; Muià C; Crisafulli C; Caputi AP; Thiemermann C
Crit Care Med; 2006 Apr; 34(4):1168-77. PubMed ID: 16484922
[TBL] [Abstract][Full Text] [Related]
6. Fumonisin b1 reduces the development of multiple organ failure induced by zymosan in mice.
Cuzzocrea S; Genovese T; Mazzon E; Esposito E; Crisafulli C; Di Paola R; Bramanti P; Salvemini D
Shock; 2009 Feb; 31(2):170-7. PubMed ID: 18650782
[TBL] [Abstract][Full Text] [Related]
7. PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
Di Paola R; Galuppo M; Mazzon E; Paterniti I; Bramanti P; Cuzzocrea S
Pharmacol Res; 2010 Feb; 61(2):175-87. PubMed ID: 19819333
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma.
Cuzzocrea S; Genovese T; Mazzon E; Crisafulli C; Di Paola R; Muià C; Collin M; Esposito E; Bramanti P; Thiemermann C
J Pharmacol Exp Ther; 2006 Jul; 318(1):79-89. PubMed ID: 16601144
[TBL] [Abstract][Full Text] [Related]
9. Ethyl pyruvate reduces the development of zymosan-induced generalized inflammation in mice.
Di Paola R; Mazzon E; Genovese T; Crisafulli C; Bramanti P; Caminiti R; Esposito E; Fink MP; Cuzzocrea S
Crit Care Med; 2009 Jan; 37(1):270-82. PubMed ID: 19050619
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3beta inhibition attenuates asthma in mice.
Bao Z; Lim S; Liao W; Lin Y; Thiemermann C; Leung BP; Wong WS
Am J Respir Crit Care Med; 2007 Sep; 176(5):431-8. PubMed ID: 17556716
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock.
Cuzzocrea S; Mazzon E; Di Paola R; Genovese T; Serraino I; Dugo L; Cuzzocrea E; Fulia F; Caputi AP; Salvemini D
Crit Care Med; 2004 Jan; 32(1):157-67. PubMed ID: 14707575
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice.
Cuzzocrea S; Crisafulli C; Mazzon E; Esposito E; Muià C; Abdelrahman M; Di Paola R; Thiemermann C
Br J Pharmacol; 2006 Nov; 149(6):687-702. PubMed ID: 17016509
[TBL] [Abstract][Full Text] [Related]
13. Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice.
Mazzon E; Esposito E; Di Paola R; Impellizzeri D; Bramanti P; Cuzzocrea S
Pharmacol Res; 2011 Jul; 64(1):68-79. PubMed ID: 21193041
[TBL] [Abstract][Full Text] [Related]
14. Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: role of glycogen synthase kinase-3beta inhibition.
Dugo L; Collin M; Allen DA; Murch O; Foster SJ; Yaqoob MM; Thiemermann C
Crit Care Med; 2006 May; 34(5):1489-96. PubMed ID: 16557150
[TBL] [Abstract][Full Text] [Related]
15. Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice.
Cuzzocrea S; Rossi A; Pisano B; Di Paola R; Genovese T; Patel NS; Cuzzocrea E; Ianaro A; Sautebin L; Fulia F; Chatterjee PK; Caputi AP; Thiemermann C
Intensive Care Med; 2003 Nov; 29(11):2016-25. PubMed ID: 12879239
[TBL] [Abstract][Full Text] [Related]
16. Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus.
Collino M; Thiemermann C; Mastrocola R; Gallicchio M; Benetti E; Miglio G; Castiglia S; Danni O; Murch O; Dianzani C; Aragno M; Fantozzi R
Shock; 2008 Sep; 30(3):299-307. PubMed ID: 18323734
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3beta inhibition attenuates the development of bleomycin-induced lung injury.
Cuzzocrea S; Genovese T; Mazzon E; Esposito E; Muià C; Abdelrahman M; Di Paola R; Bramanti P; Thiemermann C
Int J Immunopathol Pharmacol; 2007; 20(3):619-30. PubMed ID: 17880775
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of Hypericum perforatum in zymosan-induced multiple organ dysfunction syndrome: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity.
Di Paola R; Mazzon E; Muià C; Crisafulli C; Genovese T; Di Bella P; Esposito E; Menegazzi M; Meli R; Suzuki H; Cuzzocrea S
Nitric Oxide; 2007 Feb; 16(1):118-30. PubMed ID: 16889996
[TBL] [Abstract][Full Text] [Related]
19. Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice.
Mondello S; Galuppo M; Mazzon E; Italiano D; Mondello P; Aloisi C; Cuzzocrea S
Eur J Pharmacol; 2011 May; 658(1):28-40. PubMed ID: 21349270
[TBL] [Abstract][Full Text] [Related]
20. Effects of glycogen synthase kinase-3beta inhibition on the development of cerulein-induced acute pancreatitis in mice.
Cuzzocrea S; Malleo G; Genovese T; Mazzon E; Esposito E; Muià C; Abdelrahman M; Di Paola R; Thiemermann C
Crit Care Med; 2007 Dec; 35(12):2811-21. PubMed ID: 18074481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
